Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease
Clinical trial NCT07118696 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07118696
- Sponsor
- Hamilton Health Sciences Corporation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2029-01-31
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.